Lilly Eli Co (LLY)

Aug 02, 2025

The GLP-1 Gold Rush: Assessing the Financial Implications of Expanded Medicaid and Medicare Coverage for Eli Lilly and Novo Nordisk - AInvest

Aug 02, 2025

Aug 01, 2025

Why Eli Lilly Stock Topped the Market Today - The Motley Fool

Aug 01, 2025

Aug 01, 2025

Why Novo Nordisk Stock Bumped Higher on Friday - The Motley Fool

Aug 01, 2025

Aug 01, 2025

Here’s Why Eli Lilly And Novo Nordisk Stocks Are Rallying Today - Stocktwits

Aug 01, 2025

Aug 01, 2025

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and AbbVie (ABBV) - The Globe and Mail

Aug 01, 2025

Aug 01, 2025

Lilly, Novo rally after report of Medicare weight loss coverage - TipRanks

Aug 01, 2025

Aug 01, 2025

U.S. Medicare plans to cover Eli Lilly and Co and Novo-Nordisk A/S GLP-1 weight loss drugs, with a pilot program set to begin in 2026. - 富途牛牛

Aug 01, 2025

Aug 01, 2025

Positive Outlook for Eli Lilly & Co. Amid Key Trial Outcomes and Earnings Projections - TipRanks

Aug 01, 2025

Aug 01, 2025

Eli Lilly price breaches upward correctional trend lineForecast today01-08-2025 - Economies.com

Aug 01, 2025

Aug 01, 2025

Eli Lilly: The Worst May Be Already Over (Earnings Preview) (NYSE:LLY) - Seeking Alpha

Aug 01, 2025

Aug 01, 2025

Eli Lilly (LLY) Stock Rises on Medicare Weight Loss Drug Coverage Plan - GuruFocus

Aug 01, 2025

Aug 01, 2025

Exxon Mobil, Eli Lilly, Moderna - TradingView

Aug 01, 2025

Aug 01, 2025

Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued? - Morningstar

Aug 01, 2025

Aug 01, 2025

Eli Lilly and Company’s Mounjaro Displayed Cardiovascular Protection in New Head-to-Head Trial - PharmExec

Aug 01, 2025

Jul 31, 2025

Eli Lilly (LLY) Bulls Prepare for Multiyear Upside - TipRanks

Jul 31, 2025

Jul 31, 2025

Eli Lilly and Company (LLY): We Sold Some Lilly, Says Jim Cramer - Insider Monkey

Jul 31, 2025

Jul 31, 2025

Mounjaro appears more heart protective than Trulicity in trial of Eli Lilly diabetes drugs - Reuters

Jul 31, 2025

Jul 31, 2025

Eli Lilly (LLY) Reveals Promising Diabetes and Alzheimer's Trials Results - simplywall.st

Jul 31, 2025

Jul 31, 2025

Trial Finds Eli Lilly’s (LLY) Diabetes Drug Mounjaro Has Heart Health Benefits - TipRanks

Jul 31, 2025

Jul 31, 2025

Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Jul 31, 2025

Jul 31, 2025

Lilly’s Mounjaro as Effective on Heart Risks as Older Drug - Bloomberg

Jul 31, 2025

Jul 31, 2025

What Makes Eli Lilly and Company (LLY) a Lucrative Investment? - Insider Monkey

Jul 31, 2025

Jul 31, 2025

Lilly’s Mounjaro shows cardiovascular benefits in diabetes study - Investing.com

Jul 31, 2025

Jul 31, 2025

Lilly’s Mounjaro shows cardiovascular benefits in diabetes study By Investing.com - Investing.com India

Jul 31, 2025

Jul 31, 2025

Mounjaro proves more heart protective than Trulicity in trial of Eli Lilly diabetes drugs - Reuters

Jul 31, 2025

Jul 31, 2025

Eli Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment - statnews.com

Jul 31, 2025

Jul 31, 2025

Eli Lilly’s stock drops as Trump targets 17 drug makers with letters on their pricing - MarketWatch

Jul 31, 2025

Jul 30, 2025

Extension trial demonstrates long-term benefit for Lilly Alzheimer’s drug - European Pharmaceutical Review

Jul 30, 2025

Jul 30, 2025

Eli Lilly and Company (LLY): Jim Cramer’s “Bullish” On News Of Tariffs - Insider Monkey

Jul 30, 2025

Jul 30, 2025

Eli Lilly Stock (LLY) Will Benefit from ‘Onshoring Boom,’ Says BMO Capital Markets - TipRanks

Jul 30, 2025

Jul 30, 2025

Eisai/Biogen, Eli Lilly highlight long-term data backing Alzheimer’s drugs - Seeking Alpha

Jul 30, 2025

Jul 30, 2025

Lilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease - Eli Lilly and Company

Jul 30, 2025

Jul 30, 2025

Dermatology Conditions, Information & Resources - Eli Lilly

Jul 30, 2025

Jul 30, 2025

Eli Lilly Pulls Ahead In Weight-Loss Drug Race - Finimize

Jul 30, 2025

Jul 30, 2025

Novo Nordisk's stock plummets 21% as Eli Lilly faces market fluctuations in KoreaCHOSUNBIZ - Chosunbiz

Jul 30, 2025

Jul 30, 2025

Fat jab wars wipe £70bn off Ozempic maker Novo Nordisk as it feels the heat from rival Eli Lilly - MSN

Jul 30, 2025

Jul 29, 2025

Eli Lilly's CEO Pay and Its Implications for Pharma Innovation and Shareholder Value - AInvest

Jul 29, 2025

Jul 29, 2025

Assessing Eli Lilly's CEO Pay Surge: Innovation-Driven Growth and Shareholder Value Alignment - AInvest

Jul 29, 2025

Jul 29, 2025

Why Eli Lilly Stock Was Looking Sickly Today - AOL.com

Jul 29, 2025

Jul 29, 2025

Eli Lilly (LLY) Stock Dips on Novo Nordisk Guidance Update - GuruFocus

Jul 29, 2025

Jul 29, 2025

Lilly set for strong quarter after Novo profit warning - Reuters

Jul 29, 2025

Jul 29, 2025

Lilly’s Jaypirca Threatens Imbruvica’s CLL Position After Phase III Results - insights.citeline.com

Jul 29, 2025

Jul 29, 2025

Why Eli Lilly (LLY) Stock Is Falling Today - Yahoo Finance

Jul 29, 2025

Jul 29, 2025

UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on Tuesday By Investing.com - Investing.com India

Jul 29, 2025

Jul 29, 2025

UnitedHealth, Eli Lilly Lead Market Cap Stock Movers on Tuesday - Investing.com

Jul 29, 2025

Jul 29, 2025

Eli Lilly (LLY) Announces Positive Results For Jaypirca In Phase 3 Trial - Yahoo Finance

Jul 29, 2025

Jul 29, 2025

Eli Lilly strikes again in weight-loss drugs fight - Life Sciences Intellectual Property Review

Jul 29, 2025

Jul 29, 2025

What's Going On With Eli Lilly Stock On Tuesday? - inkl

Jul 29, 2025

Jul 29, 2025

Eli Lilly’s New Study on LY4088044: What Investors Need to Know - TipRanks

Jul 29, 2025

Jul 29, 2025

Eli Lilly (LLY) Maintains Strong Outlook Amid Competitor's Guidance Update - GuruFocus

Jul 29, 2025

Jul 29, 2025

JPMorgan does not see Lilly read-through from Novo cut - TipRanks

Jul 29, 2025

Jul 29, 2025

Novo Is to Lilly What LVMH Is to Hermes, Fund Manager Reckons - Bloomberg

Jul 29, 2025